CABA
CABA
NASDAQ · Biotechnology

Cabaletta Bio Inc

$1.03
-0.03 (-2.37%)
As of Nov 19, 8:40 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 13 81%
Hold 3 19%
Sell 0 0%
Price Target
Analyst Price Target +3,763.1% upside
Low Target $29.42
Average Target $39.79
High Target $58.63
Current Price $1.03
Current
$1.03
Target
$39.79
$29.42 $39.79 avg $58.63
Scenario Analysis
Bear Case
$29.42
2,756.3%
Low target
Base Case
$39.79
+3,763.1%
Avg target
Bull Case
$58.63
+5,592.2%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$4.23
-75.7% from high
52-Week Low
$1.18
+-12.7% from low
Target vs 52W High
$39.79
+840.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -9.2%
AMGN
Amgen Inc
Hold 42 43% $190.87 -56.5%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +117.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -15.8%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.7%
MRNA
Moderna Inc
Hold 31 32% $149.45 -25.0%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -28.4%